Form 4: Procter & Gamble Executive Jennifer L. Davis Reports Stock Transactions

Jennifer L. Davis, CEO of Health Care at Procter & Gamble, reported the acquisition and disposal of company stock and restricted stock units.

Summary

• Jennifer L. Davis, CEO of Health Care at Procter & Gamble, filed a Form 4 detailing changes in her beneficial ownership of company stock.
• On December 19, 2024, Davis acquired 46.27 shares of common stock at a price of $169.79, totaling 52,963.9715 shares due to dividend equivalents.
• She also disposed of 46.27 shares of common stock at $169.79 to cover taxes on a previous restricted stock unit grant, resulting in a reduction of 52,917.7015 shares.
• Additionally, 14,610.8722 shares are held indirectly through a retirement plan trustee.
• Davis also acquired 21.6833 restricted stock units (RSUs) on November 15, 2024, and 46.27 RSUs on December 19, 2024, both with a value of $0.
• These RSUs will convert to shares upon retirement, unless deferred or contributed to a deferred compensation account.

Sentiment

Score: 7

Explanation: The document reflects standard executive stock transactions, which are neither particularly positive nor negative. The sentiment is neutral to slightly positive due to the acquisition of shares through dividend equivalents and the grant of RSUs.

Positives

• The acquisition of shares through dividend equivalents indicates a positive return on investment for the reporting person.
• The grant of restricted stock units suggests a long-term incentive for the executive to remain with the company.

Negatives

• The disposal of shares to cover taxes indicates a taxable event for the executive, which may reduce the overall benefit of the RSU grant.

Risks

• The value of the restricted stock units is contingent on the company's stock price at the time of vesting or retirement.
• Changes in tax laws could impact the value of the stock transactions.

Future Outlook

The restricted stock units will deliver in shares upon retirement, unless delivery is deferred or such shares are contributed to the reporting person's deferred compensation account.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies. It provides transparency into the executive's holdings and transactions.

Comparison to Industry Standards

• Form 4 filings are standard practice for executives of publicly traded companies like Procter & Gamble, similar to filings by executives at companies such as Unilever, Colgate-Palmolive, and Kimberly-Clark.
• The transactions reported are typical for executive compensation packages that include stock options and restricted stock units, which are common across the consumer goods industry.
• The tax withholding on stock grants is a standard procedure, and the reporting of these transactions is consistent with SEC regulations.

Stakeholder Impact

• The transactions have a minimal direct impact on shareholders, as they are part of routine executive compensation.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Procter & Gamble, stock transactions, restricted stock units, Form 4, insider trading, Jennifer L. Davis, executive compensation, dividend equivalents, retirement plan